| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0059 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |